Table 3.
Top 10 most cited papers covering the topics of essential oils and COVID-19.
| Rank | Title | Type | Year [Ref] | Times of Citations | First author |
Lead author* |
||
|---|---|---|---|---|---|---|---|---|
| Name | First year reporting essential oil | Name | First year reporting essential oil | |||||
| 1 | Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil | Original research | 2020 [29] | 152 | Bui Thi Phuong Thuy | 2020 | Duong Tuan Quang | 2020 |
| 2 | COVID-19: Is there evidence for the use of herbal medicines as adjuvant symptomatic therapy? | Review | 2020 [30] | 113 | Dâmaris Silveiraa | 1996 | Jose Maria Prieto-Garcia | 2001 |
| Michael Heinrich | 1996 | |||||||
| 3 | COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties | Review | 2020 [31] | 96 | Muhammad Asifa | 2020 | – | – |
| 4 | In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria | Original research | 2021 [32] | 94 | Imane Abdelli | 2021 | Fayçal Hassani | 2008 |
| 5 | Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein | Original research | 2020 [33] | 76 | Seema A. Kulkarni | 2020 | Periyar S. Sellamuthu | 2013 |
| Thirumurthy Madhavan | 2020 | |||||||
| 6 | Aromatic herbs, medicinal plant-derived essential oils, and phytochemical extracts as potential therapies for coronaviruses: Future perspectives | Review | 2020 [34] | 57 | Mohamed N. Boukhatema | 2011 | – | – |
| 7 | Geranium and lemon essential oils and their active compounds downregulate angiotensin-converting enzyme 2 (ACE2), a SARS-CoV-2 spike receptor-binding domain, in epithelial cells | Original research | 2020 [35] | 56 | K. J. Senthil Kumar | 2020 | Sheng-Yang Wang | 2001 |
| 8 | An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses | Review | 2021 [36] | 55 | Abdul Rouf Wani | 2021 | Kanchan Yadav | 2021 |
| Manzoor Ahmad Rather | 2011 | |||||||
| 9 | Challenges at the time of COVID-19: opportunities and innovations in antivirals from nature | Review | 2020 [37] | 50 | Andreas Hensela | 2007 | – | – |
| 10 | Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts | Review | 2021 [38] | 43 | Zhonglei Wanga | 2021 | Liyan Yang | 2021 |
*Lead authors are indicated by their role as corresponding authors
a
This author also acted as corresponding author